FDA Authorizes Second Booster Dose of Pfizer-BioNTech and Moderna COVID-19 Vaccines for Older and Immunocompromised Individuals
Published: 03/30/2022
Sources:
- Food and Drug Administration,
- Centers for Disease Control and Prevention
Relevant To:
- All Healthcare Organizations
The U.S. Food and Drug Administration authorized and the CDC has recommended a second booster dose of either the Pfizer-BioNTech or the Moderna COVID-19 vaccines for older people and certain immunocompromised individuals. The FDA previously authorized a single booster dose for certain immunocompromised individuals following completion of a three-dose primary vaccination series. This action will now make a second booster dose of these vaccines available to other populations at higher risk for sev…
Sign Up for Free Trial